Contribution to the description of the β-thalassemia spectrum in Tunisia and the origin of mutation diversity

Hemoglobin

Volumn 28, Issue 3, 2004, Pages 189-195

  Chouk, Imen ^a   Daoud, Béchir Ben ^a   Mellouli, Fethi ^b   Bejaoui, Mohamed ^b   Gérard, Nathalie ^c   Dellagi, Koussay ^a   Abbes, Salem ^a,d  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Thalassemia (thal) spectrum; Origin of predominant mutations; Tunisia

Indexed keywords

ANALYTIC METHOD; ARTICLE; BETA THALASSEMIA; CODON; DENATURING GRADIENT GEL ELECTROPHORESIS; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUNISIA;

ALLELES; BETA-THALASSEMIA; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MALE; POINT MUTATION; PRENATAL DIAGNOSIS; TUNISIA;

ROMAN;

EID: 4544255724     PISSN: 03630269     EISSN: None     Source Type: Journal    
DOI: 10.1081/HEM-120040305     Document Type: Article

References (24)

1. Fattoum S, Abbes S. Some data on the epidemiology of hemoglobinopathies in Tunisia. Hemoglobin 1985; 9(4):423-429.
2. Chibani J, Vidaud M, Duquesnoy P, Berge-Lefranc JL, Pirastu M, Ellouze F, Rosa J, Goossens M. The peculiar spectrum of β-thalassemia genes in Tunisia. Hum Genet 1988; 78(2):190-192.
3. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of β-like globin genes. Hemoglobin 1982; 6(1):27-36.
4. Cai SP, Wall J, Kan YW, Chehab FF. Reverse dot blot probes for the screening of β-thalassemia mutations in Asians and American blacks. Hum Mutat 1994; 3(1):59-63.
5. Ghanem N, Girodon E, Vidaud M, Martin J, Fanen P, Plassa F, Goossens M. A comprehensive scanning method for rapid detection of β-globin gene mutations and polymorphisms. Hum Mutat 1992; 1(3):229-239.
6. Fattoum S, Guemira F, Oner C, Oner R, Li H-W, Kutlar F, Huisman THJ. β-Thalassemia, Hb S-β-thalassemia and sickle cell anemia among Tunisians. Hemoglobin 1991; 15(1):11-21.
7. Laradi S, Haj KA, Omri H, Chaieb A, Mahjoub T, Benlimam H, Amri F, Saad A, Miled A, Leturcq F, Ben Chibani J, Beldjord C. Molecular analysis and prenatal diagnosis of β-thalassemia: about our experience in central Tunisia. Ann Biol Clin (Paris) 2000; 58(4):453-460.
8. Lemsaddek W, Picanco I, Scuanes F, Mahmal L, Benchekroun S, Khattab M, Nogueira P, Osorio-Almeida L. Spectrum of β-thalassemia mutations and Hb F levels in the heterozygous Moroccan population. Am J Hematol 2003; 73(3):161-168.
9. Bennani C, Tamouza R, Rouabhi F, Benabadji M, Malou M, Elion J, Labie D, Beldjord C. The spectrum of β-thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol 1993; 84(2):335-337.
10. Waye JS, Borys S, Eng B, Patterson M, Chui DHK, Badr El-Din OM, Khairy Aref M, Afify Z. Spectrum of β-thalassemia mutations in Egypt. Hemoglobin 1999; 23(3):255-261.
11. Zahed L, Qatanani M, Nabulsi M, Taher A. β-Thalassemia mutations and haplotype analysis in Lebanon. Hemoglobin 2000; 24(4):269-276.
12. +-IVS-I-6 (T→C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin 2002; 26(1):33-40.
13. Kyriacou K, Al Quobaili F, Pavlou E, Christopoulos G, Ioannou P, Kleanthous M. Molecular characterization of β-thalassemia in Syria. Hemoglobin 2000; 24(1):1-13.
14. Cürük MA, Arpaci A, Attila G, Tuli A, Kilinç Y, Aksoy K, Yüregir GT. Genetic heterogeneity of β-thalassemia at Çukurova in southern Turkey. Hemoglobin 2001; 25(2):241-245.
15. Cao A, Goossens M, Pirastu M. β-Thalassemia mutations in Mediterranean populations. Br J Haematol 1989; 71(3):309-312.
16. Schiliro G, Mirabile E, Testa R, Russo-Mancuso G, Dibenedetto SP. Presence of hemoglobinopathies in Sicily: a historic perspective. Am J Med Genet 1997; 69(2):200-206.
17. Rosatelli MC, Dozy A, Faa V, Meloni A, Sardu R, Saba L, Kan YW, Cao A. Molecular characterization of β-thalassemia in the Sardinian population. Am J Hum Genet 1992; 50(2):422-426.
18. Varesi L, Vona G, Memmi M, Marongiu F, Ristaldi MS. β-Thalassemia mutations in Corsica. Hemoglobin 2000; 24(3):239-244.
19. Villegas A, Ropero P, Gonzalez FA, Anguita E, Espinos D. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin 2001; 25(3):273-283.
20. Kattamis C, Kattamis AC. Genotypes and phenotypes of β-thalassemia in Mediterranean populations. Pediatr Hematol Oncol 1997; 14(3):7-16.
21. Forget BG. Molecular mechanisms of β thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin, Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press, 2001; 252-276.
22. Bennani C, Bouhass R, Perrin-Pecontal P, Tamouza R, Malou M, Elion J, Trabuchet G, Beldjord C, Benabadji M, Labie D. Anthropological approach to the heterogeneity of β-thalassemia mutations in northern Africa. Hum Biol 1994; 66(3):369-382.
23. Zahed L, Demont J, Bouhass R, Trabuchet G, Hanni C, Zalouaa P, Perrin P. Origin and history of the IVSI-110 and codon 39 β-thalassemia mutations in the Lebanese population. Hum Biol 2002; 74(6):837-847.
24. Haj Khelil A, Chebil-Laradi S, Demont J, Omri H, Chekir-Ghedira L, Miled A, Chibani J, Perrin-Pecontal P. Exploration moléculaire de la globine humaine: spplication à l'amélioration de la thérapeutique des hemoglobinopathies et àla recherche de l'origine des mutations. Arab J Pharm Sci 2001; 1(9):5-14.